Spastin Antibody

NSJ Bioreagents
Product Code: NSJ-V8094
Product Group: Primary Antibodies
Supplier: NSJ Bioreagents
CodeSizePrice
NSJ-V8094-20UG20 ug£264.00
Quantity:
NSJ-V8094-100UG100 ug£534.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: Mouse IgG2a, kappa
Antibody Clonality: Monoclonal
Antibody Clone: Sp 6C6
Regulatory Status: RUO
Target Species:
  • Human
  • Mouse
  • Rat
Applications:
  • Immunofluorescence (IF)
  • Western Blot (WB)
Storage:
Store the Spastin antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Images

1 / 2
Western blot testing of human K562 and Raji cell lysate with Spastin antibody (clone Sp 6C6). Expected molecular weight: 60-70 kDa.~
2 / 2
SDS-PAGE analysis of purified, BSA-free Spastin antibody (clone Sp 6C6) as confirmation of integrity and

Western blot testing of human K562 and Raji cell lysate with Spastin antibody (clone Sp 6C6). Expected molecular weight: 60-70 kDa.~
SDS-PAGE analysis of purified, BSA-free Spastin antibody (clone Sp 6C6) as confirmation of integrity and

Further Information

Application Details :
Immunofluorescence: 1-2ug/ml,Western blot: 1-2ug/ml
Application Note:
Optimal dilution of the antibody should be determined by the researcher.
Description:
The AAA protein family members share an ATPase domain and have roles in various cellular processes including intracellular motility, membrane trafficking, proteolysis, protein folding and organelle biogenesis. Spastin, a member of the AAA protein family, is a 616 amino acid protein and is involved in the function or assembly of nuclear protein complexes. The Spastin protein is expressed ubiquitously and localizes to the nucleus and the cytoplasm, where it may also be involved in microtubule dynamics. Mutations in the Spastin gene (SPAST, SPG4) cause the most common form of spastic paraplegia 4, an autosomal dominant form of hereditary spastic paraplegia (HSP). HSPs comprise a group of inherited neurological disorders characterized by spastic lower extremity weakness due to a length-dependent, retrograde axonopathy of corticospinal motor neurons. SPAST-specific mutations account for approximately 40% of all autosomal dominant HSPs.
Format :
Purified
Formulation :
0.2 mg/ml with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Immunogen:
Recombinant full length human Spastin protein was used as the immunogen for the Spastin antibody.
Limitation:
This Spastin antibody is available for research use only.
Purity:
Protein G affinity chromatography
Species Reactivity :
Human, Mouse, Rat
Uniprot #:
Q9UP0